Register entry

Qingdao BAHEAL Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
9
Labeller names
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

9

9 active NDC listings: 9 human prescription drug. By marketing category: ANDA 9.

Dosage formNDCs
capsule4
capsule, delayed release3
tablet, film coated, extended release2
RouteNDCs
oral9
Labeller name on the listingNDCs
qingdao baheal pharmaceutical co., ltd.7
qingdao baheal pharmaceutical co. ltd.2
Catalogue

Marketed products

9
BrandGeneric nameForm / routeNDC
CELECOXIBCelecoxibcapsule, oral70247-006ANDA
CELECOXIBCelecoxibcapsule, oral70247-007ANDA
CELECOXIBCelecoxibcapsule, oral70247-008ANDA
CELECOXIBCelecoxibcapsule, oral70247-009ANDA
Metformin HydrochlorideMetformin Hydrochloride Extended-Release Tabletstablet, film coated, extended release, oral70247-018ANDA
Metformin HydrochlorideMetformin Hydrochloride Extended-Release Tabletstablet, film coated, extended release, oral70247-019ANDA
duloxetineDuloxetinecapsule, delayed release, oral70247-012ANDA
duloxetineDuloxetinecapsule, delayed release, oral70247-013ANDA
duloxetineDuloxetinecapsule, delayed release, oral70247-014ANDA
Compare

Other companies listing celecoxib

Enquiry

Common questions

Is Qingdao BAHEAL Pharmaceutical Co., Ltd. FDA approved?
Qingdao BAHEAL Pharmaceutical Co., Ltd. holds no registered establishment of its own; 9 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Qingdao BAHEAL Pharmaceutical Co., Ltd. make?
9 products are listed under Qingdao BAHEAL Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as capsule; capsule, delayed release; tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.